Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-08-20
2010-12-28
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S184100, C424S204100, C424S205100, C424S434000, C435S440000, C435S442000
Reexamination Certificate
active
07858099
ABSTRACT:
This invention relates to attenuated pestiviruses characterised in that their enzymatic activity residing in glycoprotein ERNSis inactivated, methods of preparing, using and detecting these.
REFERENCES:
patent: 4719177 (1988-01-01), Baltimore et al.
patent: 5206163 (1993-04-01), Renard et al.
patent: 6001613 (1999-12-01), Donis et al.
patent: 6168942 (2001-01-01), Cao et al.
patent: 6610305 (2003-08-01), Elbers et al.
patent: 7179473 (2007-02-01), Meyers
patent: 2003/0044426 (2003-03-01), Meyers
patent: 2004/0038198 (2004-02-01), Elbers et al.
patent: 2005/0002966 (2005-01-01), Meyers
patent: 2006/0024320 (2006-02-01), Meyers
patent: 0 794 257 (1997-09-01), None
Baker, J.C., “Bovine viral diarrhea virus: A review,”J. Am. Vet. Med. Assoc.190:1449-1458, American Veterinary Medical Association (1987).
Becher, P., et al., “Further Characterization of Border Disease Virus Isolates: Evidence for the Presence of More Than Three Species Within the Genus Pestivirus,”Virology209:200-206, Academic Press, Inc. (1995).
Beer, M., et al., “A new inactivated BVDV genotype I and II vaccine An immunisation and challenge study with BVDV genotype I,”Vet. Microbiol. 77:195-208, Elsevier Science B.V. (Nov. 2000).
Behrens, S-E., et al., “Characterization of an Autonomous Subgenomic Pestivirus RNA Replicon,”J Virol. 72:2364-2372, American Society for Microbiology (Mar. 1998).
Bolin, S.R., and Ridpath, J.F., “Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves,”Am. J. Vet. Res. 56:755-759, American Veterinary Medical Association (1995).
Bowie, J.U., et al., “Deciphering the message in protein sequences: tolerance to amino acid substitutions,”Science247:1306-1310, American Association for the Advancement of Science (1990).
Boyer, J-C., and Haenni, A-L., “Minireview: Infectious Transcripts and cDNA Clones of RNA Viruses,”Virology198:415-428, Elsevier Science B.V. (1994).
Brock, K.V., et al., “Nucleotide sequencing of 5' and 3' termini of bovine viral diarrhea virus by RNA ligation and PCR,”J. Virol. Methods38:39-46, North-Holland Biomedical Press (1992).
Chambers, T.J., et al., “Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication,”J. Virol.67:6797-6807, American Society for Microbiology (1993).
Chon, S.K., et al., “Genetic analysis of the internal ribosome entry segment of bovine viral diarrhea virus,”Virology251:370-382, Elsevier Science B.V. (Nov. 1998).
Collett, M.S., et al., “Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus,”Virology165:191-199, Elsevier Science B.V. (1988).
Cortese, V.S., et al., “Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus,”J. Am. Vet. Med. Assoc.213:1312-1319, American Veterinary Medical Association (Nov. 1998).
Cortese, V.S., et al., “Specificity And Duration of Neutralizing Antibodies Induced In Healthy Cattle After Administration Of A Modified-Live Virus Vaccine Against Bovine Viral Diarrhea,”Am. J. Vet. Res. 59:848-850, American Veterinary Medical Association (Jul. 1998).
De Smit, A.J., et al., “Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination,”Vet. Microbiol. 78:307-317, Elsevier Science B.V. (Feb. 2001).
Donis, R.O., et al., “Neutralizing Monoclonal Antibodies to Bovine Viral Diarrhoea Virus Bind to the 56K to 58K Glycoprotein,”J. Gen. Virol. 69:77-86, Society for General Microbiology (1988).
Fekadu, M., et al., “Immunogenicity, Efficacy And Safety Of An Oral Rabies Vaccine (SAG-2) In Dogs,”Vaccine14:465-468, Elsevier Science B.V. (1996).
Grebennikova, T.V., et al., “Genetic Characteristics of Hog Cholera Virus Vaccine Strains: Comparative Analysis of Primary Sequences of Surface Glycoprotein Erns, E1 and E2 Genes,”Mol. Gen. Mikrobiol. Virusol. 2:34-40, Meditsina (Jan. 1999).
Greenspan, N. S., and Di Cera, E., “Defining epitopes: It's not as easy as it seems,”Nat. Biotechnol. 17:936-937, Nature America Publishing (1999).
Gu, B., et al., “The RNA Helicase and Nucleotide Triphosphatase Activities of the Bovine Viral Diarrhea Virus NS3 Protein Are Essential for Viral Replication,”J. Virol. 74:1794-1800, American Society for Microbiology (Feb. 2000).
Houe, H., et al., “Application Of Antibody Titers Against Bovine Viral Diarrhea Virus (BVDV) As a Measure To Detect Herds With Cattle Persistently Infected With BVDV,”J. Vet. Diagn. Invest. 7:327-332, American Association Of Veterinary Laboratory Diagnosticians (1995).
Huang, Q.S., et al., “An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1,”Gene Ther. 1:300-306, Nature Publishing Group (1994).
Hulst, M.M., et al., “Glycoprotein E2 of Classical Swine Fever Virus: Expression in Insect Cells and Identification as a Ribnuclease,”Virology200:558-565, Academic Press, Inc. (1994).
Hulst, M.M., et al., “Inactivation of the RNase Activity of Glycoprotein Erns of Classical Swine Fever Virus Results in a Cytopathogenic Virus,”J. Virol. 72:151-157, American Society of Microbiology (Jan. 1998).
Kit, M. and Kit, S., “Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs,”Vet. Microbiol. 28:141-155, Elsevier Science Publishers B.V. (1991).
Kümmerer, B.M., and Meyers, G., “Correlation between Point Mutations in NS2 and the Viability and Cytopathogenicity of Bovine Viral Diarrhea Virus Strain Oregon Analyzed with an Infectious cDNA Clone,”J. Virol. 74:390-400, American Society for Microbiology (Jan. 2000).
Kupfermann, H., et al., “Bovine viral diarrhea virus: characterization of a cytopathogenic defective interfering particle with two internal deletions,”J. Virol. 70:8175-8181, American Society for Microbiology (1996).
Lai, C.J., et al., “Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus,”Proc. Natl. Acad. Sci. USA 88:5139-5143, National Academy of Sciences (1991).
Men, R., et al., “Dengue Type 4 Virus Mutants Containing Deletions in the 3' Noncoding Region of the RNA Genome: Analysis of Growth Restriction in Cell Culture and Altered Viremia Ppattern and Immunogenicity in Rhesus Monkeys,”J. Virol. 70:3930-3937, American Society for Microbiology (1996).
Mendez, E., et al., “Infectious Bovine Viral Diarrhea Virus (Strain NADL) RNA from Stable cDNA Clones: a Cellular Insert Determines NS3 Production and Viral Cytopathogenicity,”J. Virol. 72:4737-4745, American Society for Microbiology (Jun. 1998).
Meyer, C. et al., “Recovery of Virulent and RNase-Negative Attenuated Type 2 Bovine Viral Diarrhea Viruses from Infectious cDNA Clones,”J. Virol. 76:8494-8503 (2002).
Meyers, G. et al., “Bovine Viral Diarrhea Virus: Prevention of Persistent Fetal Infection by a Combination of Two Mutations Affecting ErnsRNase and NproProtease,”J. Virol. 81:3327-3338 (2007).
Meyers, G. et al., “Mutations Abrogating the RNase Activity in Glycoprotein Ernsof the Pestivirus Classical Swine Fever Virus Lead to Virus Attenuation,”J. Virol73:10224-10235 (1999).
Meyers, G., and Thiel, H-J., “Molecular Characterization of Pestiviruses,”Adv. Virus Res. 47:53-118, Academic Press (1996).
Meyers, G., et al., “Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles,”J. Virol. 70
Boehringer Ingelheim Vetmedica GmbH
Morris Michael P.
Scott Julie A.
Zeman Robert A
LandOfFree
Method for inducing an immunological response in an animal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inducing an immunological response in an animal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inducing an immunological response in an animal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4175269